Cargando…

Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry

BACKGROUND AND PURPOSE: The use of direct oral anticoagulants (DOAC) has increased sharply and DOAC are the oral anticoagulant therapy (OAT) of choice for the majority of patients with newly-diagnosed atrial fibrillation. Intracranial hemorrhage is the most severe adverse event of OAT. Systematic da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfeilschifter, Waltraud, Lindhoff-Last, Edelgard, Alhashim, Ali, Zydek, Barbara, Lindau, Simone, Konstantinides, Stavros, Grottke, Oliver, Nowak-Göttl, Ulrike, von Heymann, Christian, Birschmann, Ingvild, Beyer-Westendorf, Jan, Meybohm, Patrick, Greinacher, Andreas, Herrmann, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059415/ https://www.ncbi.nlm.nih.gov/pubmed/35491419 http://dx.doi.org/10.1186/s42466-022-00183-y

Ejemplares similares

Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry
por: Lindhoff-Last, Edelgard, et al.
Publicado: (2021)

Pharmacokinetics of Phenprocoumon in Emergency Situations–Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)
por: Lindhoff-Last, Edelgard, et al.
Publicado: (2022)

No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke
por: Bohmann, Ferdinand, et al.
Publicado: (2012)

Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry
por: Schulz, Annabel, et al.
Publicado: (2022)

New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness
por: Mani, Helen, et al.
Publicado: (2014)

The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination
por: Ott, Olivia, et al.
Publicado: (2023)

Main considerable factors for correct laboratory test interpretation under DOA treatment
por: Mani, Helen, et al.
Publicado: (2013)

Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2
por: Lindhoff-Last, Edelgard, et al.
Publicado: (2021)

Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC
por: Pfeilschifter, Waltraud, et al.
Publicado: (2011)

Thrombolysis in a Stroke Patient on Dabigatran Anticoagulation: Case Report and Synopsis of Published Cases
por: Pfeilschifter, Waltraud, et al.
Publicado: (2013)

Reproductive issues in women on direct oral anticoagulants
por: Beyer‐Westendorf, Jan, et al.
Publicado: (2021)

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015)

Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network
por: Hartmann, S, et al.
Publicado: (2016)

Evaluation of the sensitivity and specificity of a novel line immunoassay for the detection of criteria and non-criteria antiphospholipid antibodies in comparison to established ELISAs
por: Thaler, Markus A., et al.
Publicado: (2019)

Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants
por: Ay, C, et al.
Publicado: (2019)

Clinical and cardiac magnetic resonance findings in post-COVID patients referred for suspected myocarditis
por: Breitbart, Philipp, et al.
Publicado: (2021)

Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
por: Ebner, Matthias, et al.
Publicado: (2017)

Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis
por: Ebner, Matthias, et al.
Publicado: (2018)

The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
por: Beyer-Westendorf, Jan, et al.
Publicado: (2021)

The Reversal of Direct Oral Anticoagulants in Animal Models
por: Honickel, Markus, et al.
Publicado: (2017)

Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters
por: Geisen, Christof, et al.
Publicado: (2010)

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP)
por: Dempfle, Carl-Erik, et al.
Publicado: (2021)

Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC–MS/MS
por: Brückner, Lea, et al.
Publicado: (2021)

Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
por: Härtig, Florian, et al.
Publicado: (2021)

The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives
por: Lucaciu, Alexandra, et al.
Publicado: (2020)

Fingolimod for the treatment of neurological diseases—state of play and future perspectives
por: Brunkhorst, Robert, et al.
Publicado: (2014)

Luftnot und Kauderwelsch
por: Meyer, Anjela, et al.
Publicado: (2021)

In a trauma experimental pig model prothrombin complex concentrates and a specific antidote (idarucizumab) are effective to reverse the anticoagulant effects of dabigatran
por: Grottke, O, et al.
Publicado: (2014)

Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice
por: Pfeilschifter, Waltraud, et al.
Publicado: (2011)

Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolism
por: Rodionov, Roman N., et al.
Publicado: (2021)

In-line filtration of intravenous infusion may reduce organ dysfunction of adult critical patients
por: Schmitt, Elke, et al.
Publicado: (2019)

Prothrombin complex concentrate restores haemostasis in a dabigatran anticoagulated polytrauma pig model
por: Honickel, M, et al.
Publicado: (2014)

Strain-dependent interactions of Streptococcus gallolyticus subsp. gallolyticus with human blood cells
por: Grimm, Imke, et al.
Publicado: (2017)

Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
por: Fischer, Bastian, et al.
Publicado: (2021)

Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test
por: van Ommen, C. Heleen, et al.
Publicado: (2017)

Retrospective study shows that early administration of convalescent plasma in hospitalized COVID‐19 patients may have a positive effect on disease progression
por: Birschmann, Ingvild, et al.
Publicado: (2022)

Humoral and cellular immune response levels at a 1-year follow-up after mild COVID-19
por: Flieder, Tobias, et al.
Publicado: (2022)

Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis
por: Martini, Andrea, et al.
Publicado: (2021)

The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old
por: Prexl, Oliver, et al.
Publicado: (2018)

Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
por: Grottke, Oliver, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f9ev839rt02keqnsmsjd5b0lcb